Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review

2014103 citationsReview

Authors

Patrick Fleming · University of Toronto

C. Roubille · Université de Montréal

Vincent Richer · Hôpital Saint-Luc

Tara Starnino · Hôpital du Sacré-Cœur de Montréal

Collette McCourt · University of British Columbia

Alexandra McFarlane · University of Alberta

S. Siu ·

Abstract

Adalimumab, etanercept and ustekinumab were associated with statistically significant reductions in depressive symptom scores using various scales in patients with moderate-to-severe psoriasis.

Topics & Keywords

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Tryptophan and brain disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of the European Academy of Dermatology and Venereology

Volume 29, Issue 6, pp. 1063-1070

DOI: 10.1111/jdv.12909

Field-Weighted Citation Impact: 3.24